Disclosure Of Fair Value Measurement [Text Block]

HEMOGENYX PHARMACEUTICALS PLC - Filing #5969073

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
4,211,560 GBP
6,105,893 GBP
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities
3,358,066 GBP
3,324,887 GBP
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
29,423,915 GBP
21,388,546 GBP
35,045 GBP
44,020 GBP
435,955 GBP
1,508,572 GBP
6,157,894 GBP
13,983,115 GBP
853,494 GBP
2,781,006 GBP
23,804,734 GBP
1,164,637 GBP
37,723 GBP
19,938,556 GBP
11,755,660 GBP
- GBP
77,496 GBP
6,157,894 GBP
3,243,520 GBP
921,801 GBP
31,908 GBP
16,808,647 GBP
17,114,056 GBP
9,797,493 GBP
6,157,894 GBP
- GBP
980,563 GBP
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.